Franklin Resources’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.1M Sell
405,538
-45,464
-10% -$3.3M 0.01% 772
2025
Q4
$34M Sell
451,002
-279,759
-38% -$17.6M 0.01% 769
2025
Q3
$29M Sell
730,761
-121,770
-14% -$4.65M 0.01% 833
2025
Q2
$37M Sell
852,531
-23,545
-3% -$896K 0.01% 726
2025
Q1
$32.7M Buy
876,076
+9,888
+1% +$382K 0.01% 739
2024
Q4
$39.2M Buy
866,188
+5,199
+0.6% +$265K 0.01% 691
2024
Q3
$48.1M Sell
860,989
-144,481
-14% -$6.92M 0.01% 618
2024
Q2
$39.6M Sell
1,005,470
-29,910
-3% -$1.45M 0.01% 622
2024
Q1
$68.8M Sell
1,035,380
-54,400
-5% -$2.38M 0.02% 472
2023
Q4
$30.4M Buy
1,089,780
+92,423
+9% +$1.85M 0.01% 650
2023
Q3
$21.2M Buy
+997,357
New +$22M 0.01% 725

Other funds holding APGE